Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Non-Current Debt (2016 - 2026)

Nutex Health (NUTX) has disclosed Non-Current Debt for 12 consecutive years, with $24.3 million as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Debt rose 11.63% year-over-year to $24.3 million; the TTM value through Mar 2026 reached $24.3 million, up 11.63%, while the annual FY2025 figure was $29.2 million, 29.86% up from the prior year.
  • Non-Current Debt hit $24.3 million in Q1 2026 for Nutex Health, down from $29.2 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $29.2 million in Q4 2025 and bottomed at $128176.0 in Q1 2022.
  • Average Non-Current Debt over 5 years is $22.3 million, with a median of $24.3 million recorded in 2026.
  • Year-over-year, Non-Current Debt crashed 70.76% in 2022 and then soared 19488.97% in 2023.
  • Nutex Health's Non-Current Debt stood at $23.1 million in 2022, then grew by 14.16% to $26.3 million in 2023, then fell by 14.63% to $22.5 million in 2024, then rose by 29.86% to $29.2 million in 2025, then decreased by 16.84% to $24.3 million in 2026.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $24.3 million, $29.2 million, and $25.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.